Bharat Biotech developed Ebola vaccine show positive trial results on mice
Ella Foundation of Bharat Biotech has successfully tested a preliminary vaccine for Ebola on mice. Ella Foundation has been trying to discover a suitable vaccine to check the deadly viral disease that shook the world recently. Vaccine from adenovirus and glycoprotein was tested on mice and the good results were found to be for developing a full-fledged vaccine. Adenoviruses are accountable for respiratory infections, gastroenteritis, cystitis, and primary pneumonia in humans, and are used as a clear target to understand the human immunity characteristics in laboratory. However, the efficacy of the vaccine will be evaluated by the results seen in human trials.
Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strain. Ebola is a multi-organ infecting disease. The virus could spread fast through human touch. Particularly India needs to be vigilant in containing this disease. Having understood the gravity of the situation across the world due to this disease the efforts of Bharat Biotech and its foundation are hailed all over. It has not yet hit India. The worst hit part of the world is Africa.
Other major companies that are working to provide a fool proof vaccine solution to Ebola in the world are GlaxoSmitKline, Johnson & Johnson, Merck and Novavax. All these companies combined have invested an amount of approximately 500 million towards research and development of this vaccine.
Subscribe to PharmaTutor News Alerts by Email >>